Stocks and InvestingStocks and Investing
Mon, May 2, 2022
Sun, May 1, 2022
Fri, April 29, 2022

John Ransom Maintained (AMED) at Buy with Decreased Target to $180 on, Apr 29th, 2022


Published on 2024-10-27 20:44:31 - WOPRAI, John Ransom
  Print publication without navigation


John Ransom of Raymond James, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $200 to $180 on, Apr 29th, 2022.

John has made no other calls on AMED in the last 4 months.



There are 4 other peers that have a rating on AMED. Out of the 4 peers that are also analyzing AMED, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Mok of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $168 on, Tuesday, March 1st, 2022


These are the ratings of the 3 analyists that currently disagree with John


  • Matt Borsch of "BMO Capital" Upgraded from Hold to Buy and Held Target at $190 on, Friday, February 25th, 2022
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $200 on, Friday, February 25th, 2022
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $175 on, Thursday, February 24th, 2022